Publikationen

Alhubaishy B, Gakis G, Knoll T (2021)
Primary chondrosarcoma of the penis in a young patient: A case report and review of the literature.
IJU Case Rep; 4(1): 29-31; 

Augustin AM, Torre GD, Kocot A, Bley TA, Kalogirou C, Kickuth R (2021)
Endovascular therapy of arterioureteral fistulas.
Vasa; 50(3): 193-201; 

Gakis G (2021)
Re: Avelumab Maintenance Therapy for Advanced or Metastatic Urothelial Carcinoma.
Eur Urol; 79(5); 

Izquierdo-Luna JS, Norz V, Bedke J, Aufderklamm S, Amend B, Mischinger J, Gakis G, Stenzl A, Rausch S (2021)
A Modified Neobladder Technique: The "I-Pouch" - Illustration of Surgical Approach and Tricks.
Urology; 147():

Jakubietz R, Jakubietz M, Vater A, Kocot A, Kübler H, Kalogirou C (2021)
Complex Soft Tissue Defects in Operative Urology: Pedicled Perforator Flaps of the Anterior Lateral Thigh for Tissue Reconstruction of the Lower Trunk.
Urol Int; 105(5-6): 477-482; 

Kalogirou C, Linxweiler J, Schmucker P, Snaebjornsson MT, Schmitz W, Wach S, Krebs M, Hartmann E, Puhr M, Müller A, Spahn M, Seitz AK, Frank T, Marouf H, Büchel G, Eckstein M, Kübler H, Eilers M, Saar M, Junker K, Röhrig F, Kneitz B, Rosenfeldt MT, Schulze A (2021)
MiR-205-driven downregulation of cholesterol biosynthesis through SQLE-inhibition identifies therapeutic vulnerability in aggressive prostate cancer.
Nat Commun; 12(1): ;

Kalogirou C, Schwinger M, Kocot A, Riedmiller H (2021)
Troubleshooting of failed continence mechanisms in the ileocecal pouch: Operative technique and long-term results of the intussuscepted ileal nipple valve.
Int J Urol; 28(11): 1105-1111;

Lunger L, Retz M, Bandur M, Souchay M, Vitzthum E, Jäger M, Weirich G, Schuster T, Autenrieth M, Kübler H, Maurer T, Thalgott M, Herkommer K, Koll F, Gschwend JE, Nawroth R, Heck MM (2021)
KLK3 and TMPRSS2 for molecular lymph-node staging in prostate cancer patients undergoing radical prostatectomy.
Prostate Cancer Prostatic Dis; 24(2): 362-369; 

Marquardt A, Solimando AG, Kerscher A, Bittrich M, Kalogirou C, Kübler H, Rosenwald A, Bargou R, Kollmannsberger P, Schilling B, Meierjohann S, Krebs M (2021)
Subgroup-Independent Mapping of Renal Cell Carcinoma-Machine Learning Reveals Prognostic Mitochondrial Gene Signature Beyond Histopathologic Boundaries.
Front Oncol; 11():

Michalski K, Ruf J, Goetz C, Seitz AK, Buck AK, Lapa C, Hartrampf PE (2021)
Prognostic implications of dual tracer PET/CT: PSMA ligand and [18F]FDG PET/CT in patients undergoing [177Lu]PSMA radioligand therapy.
Eur J Nucl Med Mol Imaging; 48(6): 2024-2030;

Schmid SC, Seitz AK, Haller B, Fritsche HM, Huber T, Burger M, Gschwend JE, Maurer T (2021)
Final results of the PräVAC trial: prevention of wound complications following inguinal lymph node dissection in patients with penile cancer using epidermal vacuum-assisted wound closure.
World J Urol; 39(2): 613-620; 

Struck JP, Hennig MJP, Hupe MC, Moharam N, Paffenholz P, Nestler T, Frank T, Worst TS, Grabbert M, Pohlmann PF, Dogan S, Hofbauer SL, Kalogirou C, Mattigk A, Brandt MP, Krabbe LM, Reis H, Dressler FF, Kramer MW, Salem J (2021)
Discrepancy between German S3 Guideline Recommendations and Daily Urologic Practice in the Management of Nonmuscle Invasive Bladder Cancer: Results of a Binational Survey.
Urol Int; (): 1-11; 

Struck JP, Hupe MC, Heinisch A, Ozimek T, Hennig MJP, Klee M, von Klot C, Kalogirou C, Kuczyk MA, Merseburger AS, Kramer MW (2021)
RLC score (R status, lymphovascular invasion, C-reactive protein) predicts survival following radical cystectomy for muscle-invasive bladder cancer.
Aktuelle Urol; ();  

Witjes JA, Bruins HM, Cathomas R, Compérat EM, Cowan NC, Gakis G, Hernández V, Linares Espinós E, Lorch A, Neuzillet Y, Rouanne M, Thalmann GN, Veskimäe E, Ribal MJ, van der Heijden AG (2021)
European Association of Urology Guidelines on Muscle-invasive and Metastatic Bladder Cancer: Summary of the 2020 Guidelines.
Eur Urol; 79(1): 82-104; 

Bruins HM, Veskimäe E, Hernández V, Neuzillet Y, Cathomas R, Compérat EM, Cowan NC, Gakis G, Espinós EL, Lorch A, Ribal MJ, Rouanne M, Thalmann GN, Yuan Y, der Heijden AGV, Witjes JA (2020)
The Importance of Hospital and Surgeon Volume as Major Determinants of Morbidity and Mortality After Radical Cystectomy for Bladder Cancer: A Systematic Review and Recommendations by the European Association of Urology Muscle-invasive and Metastatic Bladder Cancer Guideline Panel.
Eur Urol Oncol; 3(2): 131-144;

Brumberg J, Beckl M, Dierks A, Schirbel A, Krebs M, Buck A, Kübler H, Lapa C, Seitz AK (2020)
Detection Rate of 68Ga-PSMA Ligand PET/CT in Patients with Recurrent Prostate Cancer and Androgen Deprivation Therapy.
Biomedicines; 8(11); 

Cytawa W, Seitz AK, Kircher S, Fukushima K, Tran-Gia J, Schirbel A, Bandurski T, Lass P, Krebs M, Połom W, Matuszewski M, Wester HJ, Buck AK, Kübler H, Lapa C (2020)
68Ga-PSMA I&T PET/CT for primary staging of prostate cancer.
Eur J Nucl Med Mol Imaging; 47(1): 168-177; 

Distler FA, Pahernik S, Gakis G, Hutterer G, Lebentrau S, Rink M, Nuhn P, Brookman-May S, Burger M, Gratzke C, Wolff I, May M (2020)
Adherence to the EAU guideline recommendations for systemic chemotherapy in penile cancer: results of the E-PROPS study group survey.
World J Urol; 38(10): 2523-2530; 

Gakis G (2020) 
Management of Muscle-invasive Bladder Cancer in the 2020s: Challenges and Perspectives.
Eur Urol Focus; 6(4): 632-638; 

Gakis G, Bruins HM, Cathomas R, Compérat EM, Cowan NC, van der Heijden AG, Hernández V, Linares Espinós EE, Lorch A, Neuzillet Y, Ribal MJ, Rouanne M, Thalmann GN, Veskimäe E, Witjes AJ (2020)
European Association of Urology Guidelines on Primary Urethral Carcinoma-2020 Update.
Eur Urol Oncol; 3(4): 424-432;

Gakis G, Hassan FN, Schmid MA, Oelschlaeger M, Hackenberg S, Stenzl A, Renninger M (2020)
Prognostic significance of previous tonsillectomy after radical cystectomy for bladder cancerScand J Urol; 54(4): 297-303; Kalogirou C, Ellinger J, Kristiansen G, Hatzichristodoulou G, Kübler H, Kneitz B, Busch J, Fendler A (2020)
Identification of miR-21-5p and miR-210-3p serum levels as biomarkers for patients with papillary renal cell carcinoma: a multicenter analysis.
Transl Androl Urol; 9(3): 1314-1322; 

Gakis G, Karl A, Bertz S, Burger M, Fritsche HM, Hartmann A, Jokisch F, Kempkensteffen C, Miller K, Mundhenk J, Schneevoigt BS, Schubert T, Schwentner C, Wullich B, Stenzl A (2020)
Transurethral en bloc submucosal hydrodissection vs conventional resection for resection of non-muscle-invasive bladder cancer (HYBRIDBLUE): a randomised, multicentre trial.
BJU Int. 126(4): 509-519.

Grimm MO, van der Heijden AG, Colombel M, Muilwijk T, Martínez-Piñeiro L, Babjuk MM, Türkeri LN, Palou J, Patel A, Bjartell AS, Caris C, Schipper RG, Witjes WPJ, EAU Research Foundation NIMBUS Study Group (2020)
Treatment of High-grade Non-muscle-invasive Bladder Carcinoma by Standard Number and Dose of BCG Instillations Versus Reduced Number and Standard Dose of BCG Instillations: Results of the European Association of Urology Research Foundation Randomised Phase III Clinical Trial "NIMBUS".
Eur Urol; 78(5): 690-698;

Hartrampf PE, Heinrich M, Seitz AK, Brumberg J, Sokolakis I, Kalogirou C, Schirbel A, Kübler H, Buck AK, Lapa C, Krebs M (2020)
Metabolic Tumour Volume from PSMA PET/CT Scans of Prostate Cancer Patients during Chemotherapy-Do Different Software Solutions Deliver Comparable Results?
J. Clin. Med.; 9(5); 

Hartrampf PE, Seitz AK, Krebs M, Buck AK, Lapa C (2020)
False-negative 18F-PSMA-1007 PET/CT in metastatic prostate cancer related to high physiologic liver uptake.
Eur J Nucl Med Mol Imaging; 47(8): 2044-2046; 

Herzog AL, Kalogirou C, Wanner C, Lopau K (2020)
Comparison of different algorithms for the assessment of cardiovascular risk after kidney transplantation by the time of entering waiting list.
Clin Kidney J; 13(2): 150-158; 

Kalogirou C, Krebs M[Metabolic profiling and prostate cancer risk: opportunity for liquid biopsies? : Results from the prospective, case-controlled EPIC study].Urologe A; 59(7): 839-840; Grüllich C, Kübler H (2020)
[Urothelial carcinoma: immuno-oncology on all fronts].
Urologe A; 59(7); 

Kaymak I, Maier CR, Schmitz W, Campbell AD, Dankworth B, Ade CP, Walz S, Paauwe M, Kalogirou C, Marouf H, Rosenfeldt MT, Gay DM, McGregor GH, Sansom OJ, Schulze A (2020)
Mevalonate Pathway Provides Ubiquinone to Maintain Pyrimidine Synthesis and Survival in p53-Deficient Cancer Cells Exposed to Metabolic Stress.
Cancer Res; 80(2): 189-203;  

Kramer MW, Gakis G (2020)
[Immuno-oncological therapeutic options in high-risk non-muscle invasive bladder cancer].
Urologe A; 59(7): 784-789; 

Krebs M, Solimando AG, Kalogirou C, Marquardt A, Frank T, Sokolakis I, Hatzichristodoulou G, Kneitz S, Bargou R, Kübler H, Schilling B, Spahn M, Kneitz B (2020)
miR-221-3p Regulates VEGFR2 Expression in High-Risk Prostate Cancer and Represents an Escape Mechanism from Sunitinib In Vitro.
J. Clin. Med.; 9(3); 

Mottet N, Ribal MJ, Boyle H, De Santis M, Caillet P, Choudhury A, Garg T, Nielsen M, Wüthrich P, Gust KM, Shariat SF, Gakis G (2020)
Management of bladder cancer in older patients: Position paper of a SIOG Task Force.
J Geriatr Oncol; 11(7): 1043-1053; 

Petrylak DP, de Wit R, Chi KN, Drakaki A, Sternberg CN, Nishiyama H, Castellano D, Hussain SA, Fléchon A, Bamias A, Yu EY, van der Heijden MS, Matsubara N, Alekseev B, Necchi A, Géczi L, Ou YC, Coskun HS, Su WP, Bedke J, Gakis G, Percent IJ, Lee JL, Tucci M, Semenov A, Laestadius F, Peer A, Tortora G, Safina S, Garcia Del Muro X, Rodriguez-Vida A, Cicin I, Harputluoglu H, Tagawa ST, Vaishampayan U, Aragon-Ching JB, Hamid O, Liepa AM, Wijayawardana S, Russo F, Walgren RA, Zimmermann AH, Hozak RR, Bell-McGuinn KM, Powles T, RANGE study investigators (2020)
Ramucirumab plus docetaxel versus placebo plus docetaxel in patients with locally advanced or metastatic urothelial carcinoma after platinum-based therapy (RANGE): overall survival and updated results of a randomised, double-blind, phase 3 trial.
Lancet Oncol; 21(1): 105-120;

Renninger M, Fahmy O, Schubert T, Schmid MA, Hassan F, Stenzl A, Gakis G (2020)
The prognostic impact of hexaminolevulinate-based bladder tumor resection in patients with primary non-muscle invasive bladder cancer treated with radical cystectomy.
World J Urol; 38(2): 397-406; 

Schmid SC, Koll FJ, Beckert F, Seitz AK (2020)
[Immuno-oncological approaches in the perioperative therapy of muscle invasive bladder cancer].Urologe A; 59(7): 790-796; 

Schmid SC, Koll FJ, Rödel C, Maisch P, Sauter A, Beckert F, Seitz A, Kübler H, Flentje M, Chun F, Combs SE, Schiller K, Gschwend JE, Retz M (2020)
Radiation therapy before radical cystectomy combined with immunotherapy in locally advanced bladder cancer - study protocol of a prospective, single arm, multicenter phase II trial (RACE IT).
BMC Cancer; 20(1); 

Schubert T, Renninger M, Schmid MA, Hassan FN, Sokolakis I, Fahmy O, Hatzichristodoulou G, Stenzl A, Gakis G (2020)
Prognostic impact of tumor-associated immune cell infiltrates at radical cystectomy for bladder cancer.
Urol Oncol; 38(1): 4.e7-4.e15; 

Sokolakis I, Schönbauer P, Mykoniatis I, Kübler H, Gschwend J, Lahme S, Hatzichristodoulou G (2020)
Long-Term Results after Surgical Treatment of Congenital Penile Curvature Using a Modified Nesbit Technique.
World J Mens Health; 38(4): 564-572; 

Witjes JA, Babjuk M, Bellmunt J, Bruins HM, De Reijke TM, De Santis M, Gillessen S, James N, Maclennan S, Palou J, Powles T, Ribal MJ, Shariat SF, Van Der Kwast T, Xylinas E, Agarwal N, Arends T, Bamias A, Birtle A, Black PC, Bochner BH, Bolla M, Boormans JL, Bossi A, Briganti A, Brummelhuis I, Burger M, Castellano D, Cathomas R, Chiti A, Choudhury A, Compérat E, Crabb S, Culine S, De Bari B, De Blok W, De Visschere PJL, Decaestecker K, Dimitropoulos K, Dominguez-Escrig JL, Fanti S, Fonteyne V, Frydenberg M, Futterer JJ, Gakis G, Geavlete B, Gontero P, Grubmüller B, Hafeez S, Hansel DE, Hartmann A, Hayne D, Henry AM, Hernandez V, Herr H, Herrmann K, Hoskin P, Huguet J, Jereczek-Fossa BA, Jones R, Kamat AM, Khoo V, Kiltie AE, Krege S, Ladoire S, Lara PC, Leliveld A, Linares-Espinós E, Løgager V, Lorch A, Loriot Y, Meijer R, Mir MC, Moschini M, Mostafid H, Müller AC, Müller CR, N'Dow J, Necchi A, Neuzillet Y, Oddens JR, Oldenburg J, Osanto S, Oyen WJG, Pacheco-Figueiredo L, Pappot H, Patel MI, Pieters BR, Plass K, Remzi M, Retz M, Richenberg J, Rink M, Roghmann F, Rosenberg JE, Rouprêt M, Rouvière O, Salembier C, Salminen A, Sargos P, Sengupta S, Sherif A, Smeenk RJ, Smits A, Stenzl A, Thalmann GN, Tombal B, Turkbey B, Lauridsen SV, Valdagni R, Van Der Heijden AG, Van Poppel H, Vartolomei MD, Veskimäe E, Vilaseca A, Rivera FAV, Wiegel T, Wiklund P, Willemse PM, Williams A, Zigeuner R, Horwich A (2020)Corrigendum to 'EAU-ESMO Consensus Statements on the Management of Advanced and Variant Bladder Cancer-An International Collaborative Multistakeholder Effort Under the Auspices of the EAU-ESMO Guidelines Committees' [European Urology 77 (2020)
223-250].Eur Urol; 78(1): e48-e50; 

Witjes JA, Babjuk M, Bellmunt J, Bruins HM, De Reijke TM, De Santis M, Gillessen S, James N, Maclennan S, Palou J, Powles T, Ribal MJ, Shariat SF, Der Kwast TV, Xylinas E, Agarwal N, Arends T, Bamias A, Birtle A, Black PC, Bochner BH, Bolla M, Boormans JL, Bossi A, Briganti A, Brummelhuis I, Burger M, Castellano D, Cathomas R, Chiti A, Choudhury A, Compérat E, Crabb S, Culine S, De Bari B, De Blok W, J L De Visschere P, Decaestecker K, Dimitropoulos K, Dominguez-Escrig JL, Fanti S, Fonteyne V, Frydenberg M, Futterer JJ, Gakis G, Geavlete B, Gontero P, Grubmüller B, Hafeez S, Hansel DE, Hartmann A, Hayne D, Henry AM, Hernandez V, Herr H, Herrmann K, Hoskin P, Huguet J, Jereczek-Fossa BA, Jones R, Kamat AM, Khoo V, Kiltie AE, Krege S, Ladoire S, Lara PC, Leliveld A, Linares-Espinós E, Løgager V, Lorch A, Loriot Y, Meijer R, Mir MC, Moschini M, Mostafid H, Müller AC, Müller CR, N'Dow J, Necchi A, Neuzillet Y, Oddens JR, Oldenburg J, Osanto S, J G Oyen W, Pacheco-Figueiredo L, Pappot H, Patel MI, Pieters BR, Plass K, Remzi M, Retz M, Richenberg J, Rink M, Roghmann F, Rosenberg JE, Rouprêt M, Rouvière O, Salembier C, Salminen A, Sargos P, Sengupta S, Sherif A, Smeenk RJ, Smits A, Stenzl A, Thalmann GN, Tombal B, Turkbey B, Lauridsen SV, Valdagni R, Der Heijden AGV, Van Poppel H, Vartolomei MD, Veskimäe E, Vilaseca A, Rivera FAV, Wiegel T, Wiklund P, Williams A, Zigeuner R, Horwich A (2020)
EAU-ESMO Consensus Statements on the Management of Advanced and Variant Bladder Cancer-An International Collaborative Multistakeholder Effort†: Under the Auspices of the EAU-ESMO Guidelines Committees.
Eur Urol; 77(2): 223-250; 

Bruins HM, Veskimäe E, Hernández V, Neuzillet Y, Cathomas R, Compérat EM, Cowan NC, Gakis G, Espinós EL, Lorch A, Ribal MJ, Rouanne M, Thalmann GN, Yuan Y, der Heijden AGV, Witjes JA. (2019)
The Importance of Hospital and Surgeon Volume as Major Determinants of Morbidity and Mortality After Radical Cystectomy for Bladder Cancer: A Systematic Review and Recommendations by the European Association of Urology Muscle-invasive and Metastatic Bladder Cancer GuidelinePanel.
Eur Urol Oncol.

Cytawa W, Seitz AK, Kircher S, Fukushima K, Tran-Gia J, Schirbel A, Bandurski T, Lass P, Krebs M, Połom W, Matuszewski M, Wester HJ, Buck AK, Kübler H, Lapa C. (2019)
68Ga-PSMA I&T PET/CT for primary staging of prostate cancer.
Eur J Nucl Med Mol Imaging. Jan;47(1):168-177.

Distler FA, Pahernik S, Gakis G, Hutterer G, Lebentrau S, Rink M, Nuhn P, Brookman-May S, Burger M, Gratzke C, Wolff I, May M. (2019)
Adherence to the EAU guideline recommendations for systemic chemotherapy in penile cancer: results of the E-PROPS study group survey.
World J Urol.

Gakis G, Volkmer B, Qvick B, Marteau F, Stenzl A. (2019)
[Cost-effectiveness analysis of blue light cystoscopy with hexylaminolevulinate in transurethral resection of the bladder].
Urologe A. Jan;58(1):34-40.

Hartrampf PE, Seitz AK, Krebs M, Buck AK, Lapa C. (2019)
False-negative 18F-PSMA-1007 PET/CT in metastatic prostate cancer related to high physiologic liver uptake.
Eur J Nucl Med Mol Imaging.

Horwich A, Babjuk M, Bellmunt J, Bruins HM, Reijke TM, Santis M, Gillessen S, James N, Maclennan S, Palou J, Powles T, Ribal MJ, Shariat SF, Kwast TV, Xylinas E, Agarwal N, Arends T, Bamias A, Birtle A, Black PC, Bochner BH, Bolla M, Boormans JL, Bossi A, Briganti A, Brummelhuis I, Burger M, Castellano D, Cathomas R, Chiti A, Choudhury A, Compérat E, Crabb S, Culine S, Bari B, Blok W, De Visschere PJL, Decaestecker K, Dimitropoulos K, Dominguez-Escrig JL, Fanti S, Fonteyne V, Frydenberg M, Futterer JJ, Gakis G, Geavlete B, Gontero P, Grubmüller B, Hafeez S, Hansel DE, Hartmann A, Hayne D, Henry AM, Hernandez V, Herr H, Herrmann K, Hoskin P, Huguet J, Jereczek-Fossa BA, Jones R, Kamat AM, Khoo V, Kiltie AE, Krege S, Ladoire S, Lara PC, Leliveld A, Linares-Espinós E, Løgager V, Lorch A, Loriot Y, Meijer R, Mir MC, Moschini M, Mostafid H, Müller AC, Müller CR, N'Dow J, Necchi A, Neuzillet Y, Oddens JR, Oldenburg J, Osanto S, Oyen WJG, Pacheco-Figueiredo L, Pappot H, Patel MI, Pieters BR, Plass K, Remzi M, Retz M, Richenberg J, Rink M, Roghmann F, Rosenberg JE, Rouprêt M, Rouvière O, Salembier C, Salminen A, Sargos P, Sengupta S, Sherif A, Smeenk RJ, Smits A, Stenzl A, Thalmann GN, Tombal B, Turkbey B, Lauridsen SV, Valdagni R, Van Der Heijden AG, Van Poppel H, Vartolomei MD, Veskimäe E, Vilaseca A, Rivera FAV, Wiegel T, Wiklund P, Williams A, Zigeuner R, Witjes JA. (2019)
EAU-ESMO consensus statements on the management of advanced and variant bladder cancer-an international collaborative multi-stakeholder effort: under the auspices of the EAU and ESMO Guidelines Committees†.
Ann Oncol. Nov 1;30(11):1697-1727.

Hupe MC, Gakis G, Seiler R. (2019)
[Molecular tumor board-urothelial cancer].
Urologe A. Jul;58(7):760-767.

Kalampokis N, Grivas N, Ölschläger M, Hassan FN, Gakis G. (2019)
Radical Cystectomy in Female Patients - Improving Outcomes.
Curr Urol Rep. Nov 28;20(12):83.

Kalogirou C, Breshnev S, Krebs M, Koneval L, Sokolakis I, Kübler H, Riedmiller H, Kocot A. (2019)
Cognitive Status and Functional Dexterity as Outcome Predictors Following Urinary Diversion: A Combined Retrospective and Prospective Observational Study.
Urol Int. 102(2):224-232.

Kaymak I, Maier CR, Schmitz W, Campbell AD, Dankworth B, Ade CP, Walz S, Paauwe M, Kalogirou C, Marouf H, Rosenfeldt MT, Gay DM, McGregor GH, Sansom OJ, Schulze A. (2019)
Mevalonate Pathway Provides Ubiquinone to Maintain Pyrimidine Synthesis and Survival in p53-Deficient Cancer Cells Exposed to Metabolic Stress.
Cancer Res. Nov 19.

Kiener M, Chen L, Krebs M, Grosjean J, Klima I, Kalogirou C, Riedmiller H, Kneitz B, Thalmann GN, Snaar-Jagalska E, Spahn M, Kruithof-de Julio M, Zoni E. (2019)
miR-221-5p regulates proliferation and migration in human prostate cancer cells and reduces tumor growth in vivo.
BMC Cancer. Jun 25;19(1):627.

Krebs M, Behrmann C, Kalogirou C, Sokolakis I, Kneitz S, Kruithof-de Julio M, Zoni E, Rech A, Schilling B, Kübler H, Spahn M, Kneitz B. (2019)
miR-221 Augments TRAIL-Mediated Apoptosis in Prostate Cancer Cells by Inducing Endogenous TRAIL Expression and Targeting the Functional Repressors SOCS3 and PIK3R1.
Biomed Res Int.

Kübler H, Merseburger AS. (2019)
[Molecular tumor board in uro-oncology].
Urologe A. Jul;58(7):745-746.

Lebentrau S, Wolff I, Hempel MC, Haccius M, Kluth LA, Pycha A, Brookman-May S, Schneider TR, Hermanns T, Distler FA, Boegemann M, Kübler H, Shariat SF, Burger M, May M. (2019)
[Knowledge of German-speaking urologists regarding the association between penile cancer and human papilloma virus: results of a survey of the European PROspective Penile Cancer Study (E-PROPS)].
Aktuelle Urol. Nov 19.

Lukaszyk D, Krebs M, Kübler H, Kocot A, Hatzichristodoulou G. (2019)
[Bilateral intrauterine testicular torsion in a mature newborn].
Urologe A. Oct;58(10):1198-1200.

Petrylak DP, de Wit R, Chi KN, Drakaki A, Sternberg CN, Nishiyama H, Castellano D, Hussain SA, Fléchon A, Bamias A, Yu EY, van der Heijden MS, Matsubara N, Alekseev B, Necchi A, Géczi L, Ou YC, Coskun HS, Su WP, Bedke J, Gakis G, Percent IJ, Lee JL, Tucci M, Semenov A, Laestadius F, Peer A, Tortora G, Safina S, Garcia Del Muro X, Rodriguez-Vida A, Cicin I, Harputluoglu H, Tagawa ST, Vaishampayan U, Aragon-Ching JB, Hamid O, Liepa AM, Wijayawardana S, Russo F, Walgren RA, Zimmermann AH, Hozak RR, Bell-McGuinn KM, Powles T; RANGE study investigators.(2019)
Ramucirumab plus docetaxel versus placebo plus docetaxel in patients with locally advanced or metastatic urothelial carcinoma after platinum-based therapy (RANGE): overall survival and updated results of a randomised, double-blind, phase 3 trial.
Lancet Oncol. Nov 18. pii: S1470-2045(19)30668-0.

Reibetanz J, Rinn B, Kunz AS, Flemming S, Ronchi CL, Kroiss M, Deutschbein T, Pulzer A, Hahner S, Kocot A, Germer CT, Fassnacht M, Jurowich C. (2019)
Patterns of Lymph Node Recurrence in Adrenocortical Carcinoma: Possible Implications for Primary Surgical Treatment.
Ann Surg Oncol. Feb;26(2):531-538.

Renninger M, Fahmy O, Schubert T, Schmid MA, Hassan F, Stenzl A, Gakis G. (2019)
The prognostic impact of hexaminolevulinate-based bladder tumor resection in patients with primary non-muscle invasive bladder cancer treated with radical cystectomy.
World J Urol. Apr 27.

Schubert T, Renninger M, Schmid MA, Hassan FN, Sokolakis I, Fahmy O, Hatzichristodoulou G, Stenzl A, Gakis G. (2019)
Prognostic impact of tumor-associated immune cell infiltrates at radical cystectomy for bladder cancer.
Urol Oncol. 2020 Jan;38(1):4.e7-4.e15.

Seitz AK, Heck MM, Kamer MW, Grüllich C. (2019)
[Molecular tumor board prostate cancer].
Urologe A. Jul;58(7):752-759.

Sokolakis I, Schönbauer P, Mykoniatis I, Kübler H, Gschwend J, Lahme S, Hatzichristodoulou G. (2019)
Long-Term Results after Surgical Treatment of Congenital Penile Curvature Using a Modified Nesbit Technique.
World J Mens Health.

Sokolakis I, Schubert T, Oelschlaeger M, Krebs M, Gschwend JE, Holzapfel K, Kübler H, Gakis G, Hatzichristodoulou G. (2019)
The Role of Magnetic Resonance Imaging in the Diagnosis of Penile Fracture in Real-Life Emergency Settings: Comparative Analysis with Intraoperative Findings.
J Urol. Sep;202(3):552-557.

Spachmann PJ, Breyer J, Kalogirou C, Lausenmeyer EM, Weber F, Prohaska S, Denzinger S, Burger M, Kübler H, Otto W, Vergho D. (2019)
Impact of E-Cadherin and β-Catenin as Prognostic Factor in Renal Cell Carcinoma with Tumor Thrombus of the Vena Cava.
Urol Int. 102(4):413-420.

Stock KF, Slotta-Huspenina J, Kübler H, Autenrieth M. (2019)
[Innovative ultrasound-based diagnosis of renal tumors].
Urologe A. Dec;58(12):1418-1428.

Witjes JA, Babjuk M, Bellmunt J, Bruins HM, De Reijke TM, De Santis M, Gillessen S, James N, Maclennan S, Palou J, Powles T, Ribal MJ, Shariat SF, Der Kwast TV, Xylinas E, Agarwal N, Arends T, Bamias A, Birtle A, Black PC, Bochner BH, Bolla M, Boormans JL, Bossi A, Briganti A, Brummelhuis I, Burger M, Castellano D, Cathomas R, Chiti A, Choudhury A, Compérat E, Crabb S, Culine S, De Bari B, De Blok W, J L De Visschere P, Decaestecker K, Dimitropoulos K, Dominguez-Escrig JL, Fanti S, Fonteyne V, Frydenberg M, Futterer JJ, Gakis G, Geavlete B, Gontero P, Grubmüller B, Hafeez S, Hansel DE, Hartmann A, Hayne D, Henry AM, Hernandez V, Herr H, Herrmann K, Hoskin P, Huguet J, Jereczek-Fossa BA, Jones R, Kamat AM, Khoo V, Kiltie AE, Krege S, Ladoire S, Lara PC, Leliveld A, Linares-Espinós E, Løgager V, Lorch A, Loriot Y, Meijer R, Mir MC, Moschini M, Mostafid H, Müller AC, Müller CR, N'Dow J, Necchi A, Neuzillet Y, Oddens JR, Oldenburg J, Osanto S, J G Oyen W, Pacheco-Figueiredo L, Pappot H, Patel MI, Pieters BR, Plass K, Remzi M, Retz M, Richenberg J, Rink M, Roghmann F, Rosenberg JE, Rouprêt M, Rouvière O, Salembier C, Salminen A, Sargos P, Sengupta S, Sherif A, Smeenk RJ, Smits A, Stenzl A, Thalmann GN, Tombal B, Turkbey B, Lauridsen SV, Valdagni R, Der Heijden AGV, Van Poppel H, Vartolomei MD, Veskimäe E, Vilaseca A, Rivera FAV, Wiegel T, Wiklund P, Williams A, Zigeuner R, Horwich A. (2019)
EAU-ESMO Consensus Statements on the Management of Advanced and Variant Bladder Cancer-An International Collaborative Multistakeholder Effort†: Under the Auspices of the EAU-ESMO Guidelines Committees.
Eur Urol. Nov 16. pii: S0302-2838(19)30763-8.

Fahmy O, Khairul-Asri MG, Schubert T, Renninger M, Kübler H, Stenzl A, Gakis G (2018) Urethral recurrence after radical cystectomy for urothelial carcinoma: A systematic review and meta-analysis.
Urol Oncol, Feb;36(2):54-59.

Fahmy O, Khairul-Asri MG, Schubert T, Renninger M, Malek R, Kübler H, Stenzl A, Gakis G (2018)
A systematic review and meta-analysis on the oncological long-term outcomes after trimodality therapy and radical cystectomy with or without neoadjuvant chemotherapy for muscle-invasive bladder cancer.
Urol Oncol, Feb;36(2):43-53.

Gakis G, Schubert T, Morgan TM, Daneshmand S, Keegan KA, Mischinger J, Clayman RH, Brisuda A, Ali-El-Dein B, Galland S, Gregg J, Balci M, Olugbade K Jr, Rink M, Fritsche HM, Burger M, Babjuk M, Stenzl A, Thalmann GN, Kübler H, Efstathiou JA (2018)
The prognostic effect of salvage surgery and radiotherapy in patients with recurrent primary urethral carcinoma.
Urol Oncol, Jan;36(1):10.e7-10.e14.

Gakis G, Volkmer B, Qvick B, Marteau F, Stenzl A (2019)
Cost-effectiveness analysis of blue light cystoscopy with hexylaminolevulinate in transurethral resection of the bladder.
Urologe A, 58(1):34-40. [Epub 2018]

Hatzichristodoulou G (2018)
Introducing the Ventral Sealing Technique using collagen fleece for surgical therapy of patients with ventral Peyronie’s curvature: initial experience.
Int J Impot Res, 30:306–311.

Hatzichristodoulou G (2018)
Patient’s choice of health information and treatment modality for Peyronie’s disease: a long term assessment.
Int J Impot Res, 30(5): 274-275.

Hatzichristodoulou G (2018)
The PICS Technique: A novel approach for residual curvature correction during penile prosthesis implantation in patients with severe Peyronie’s disease using the collagen fleece TachoSil®.
J Sex Med, 15(3):416-421.

Herzog AL, Kalogirou C, Wanner C, Lopau K (2018)
Safety and Efficacy of Induction Therapy With Thymoglobulin in AB0-Incompatible Kidney Transplantation.
Transplantation proceedings, 50(1):53-59.

Kalogirou C, Breshnev S, Krebs M, Koneval L, Sokolakis I, Kübler H, Riedmiller H, Kocot A (2019)
Cognitive Status and Functional Dexterity as Outcome Predictors following Urinary Diversion: A Comined Retrospective and Prospective Observational Study.
Urol int, 21;102(2):224-232. [Epub 2018]

Mari A, Campi R, Tellini R, Gandaglia G, Albisinni S, Abufaraj M, Hatzichristodoulou G, Montorsi F, van Velthoven R, Carini M, Minervini A, Shariat SF (2018)
Patterns and predictors of recurrence after open radical cystectomy for bladder cancer: a comprehensive review of the literature.
World J Urol, 36(2):157-170.

Mischinger J, Abdelhafez MF, Rausch S, Todenhöfer T, Neumann E, Aufderklamm S, Stenzl A, Gakis G (2018)
Perioperative morbidity, bowel function and oncologic outcome after radical cystectomy and ileal orthotopic neobladder reconstruction: Studer-pouch versus I-pouch.
Eur J Surg Oncol, Jan;44(1):178-184

Oelschläger M, Sokolakis I, Kalogirou C, Frey L, Riedmiller H, Kübler H, Kellersmann R, Vergho D (2018)
Repair of an Autologous Saphenous Vein Graft Aneurysm Ten Years after Renal Artery Reconstruction during Live Donor Renal Transplantation.
Urol int, 101(2):236-239.

Reibetanz J, Rinn B, Kunz AS, Flemming S, Ronchi CL, Kroiss M, Deutschbein T,  Pulzer A, Hahner S, Kocot A, Germer CT, Fassnacht M, Jurowich C (2018)
Patterns of Lymph Node Recurrence in Adrenocortical Carcinoma: Possible Implications for Primary Surgical Treatment.
Ann Surg Oncol, Nov 15;26(2).

Riedmiller H, Kocot A, Kalogirou C (2018)
Serous-lined, stapled pouch wall plication: initial results of a simple and quick novel continence mechanism in troubleshooting secondary to continent cutaneous urinary diversion.
BJU Int, Jan;121(1):155-159.

Rosenhammer B, Sayedahmed K, Fritsche HM, Burger M, Kübler H, Hatzichristodoulou G (2018)
Long-term outcome after grafting with small intestinal submucosa and collagen fleece in patients with Peyronie’s disease - a matched pair analysis.
Int J Impot Res.

Seitz AK, Rauscher I, Krönke M, Luther S, Heck M, Horn T, Gschwend JE, Schwaiger M, Eiber M, Maurer T (2018)
Preliminary results on response assessment using 68Ga-HBED-CC-PSMA PET/CT in metastatic prostate cancer patients undergoing docetaxel chemotherapy.
Eur J Nucl Med Mol Imaging, Apr;45(4):602-612.

Sokolakis I, Hatzichristodoulou G (2018)
LI-ESWT zur Behandlung der ED – Wo stehen wir?
UroForum, 9(03/18):38-39.

Sokolakis I, Hatzichristodoulou G (2018)
mpMRT/TRUS Fusionsbiopsie-Systeme im Vergleich.
UroForum, 9(11/18):32-34.

Sokolakis I, Hatzichristodoulou G (2018)
Zukunftsperspektiven der extrakorporalen Stoßwellentherapie.
Uro-News, 22(5):38-43.

Yafi FA, Andrianne R, Alzweri L, Brady J, Butcher M, Chevalier D, DeLay KJ, Faix A, Hatzichristodoulou G, Hellstrom WJG, Jenkins L, Kohler TS, Osmonov D, Park SH, Schwabb D, Valenzuela R, van Renterghem K, Wilson SK (2018)
Andrianne Mini-jupette graft at the time of inflatable penile prosthesis placement for the management of post-prostatectomy climacturia and minimal urinary incontinence.
J Sex Med, 15(5):789-796.

Yafi FA, Diao L, DeLay K, DeYoung L, Talib R, Alzweri L, Brock G, Hellstrom WJG, Hatzichristodoulou G (2018)
Multi-institutional prospective analysis of intralesional injection of Collagenase Clostridium Histolyticum, tunical plication and partial plaque excision and grafting for the management of Peyronie’s disease.
Urology, 120(10):138-142.

Altieri B, Sbiera S, Della Casa S, Weigand I, Wild V, Steinhauer S, Fadda G, Kocot A, Bekteshi M, Mambretti EM, Rosenwald A, Pontecorvi A, Fassnacht M, Ronchi CL (2017)
Livin/BIRC7 expression as malignancy marker in adrenocortical tumors.
Oncotarget, Feb;8:9323-9338.

Anaissie J, DeLay KJ, Wang W, Hatzichristodoulou G, Hellstrom WJG (2017)
Testosterone deficiency in adults and corresponding treatment patterns around the globe.
Transl Androl Urol, 6(2):183-191.

Campi R, Minervini A, Mari A, Hatzichristodoulou G, Sessa F, Lapini A, Sessa M, Gschwend JE, Serni S, Roscigno M, Carini M (2017)
Anatomical Templates of Lymph Node Dissection for Upper Tract Urothelial Carcinoma:  A Systematic Review of the Literature.
Expert Rev Anticancer Ther, 17(3):235-246.

Cordon BH, Osmonov D, Hatzichristodoulou G, Morey AF (2017)
Peyronie’s penile plication.
Transl Androl Urol, 6(4):639-644.

Fahmy O, Khairul-Asri MG, Hadi SHSM, Gakis G, Stenzl A (2017)
The Role of Radical Prostatectomy and Radiotherapy in Treatment of Locally Advanced Prostate Cancer: A Systematic Review and Meta-Analysis.
Urol Int, 99(3):249-256.

Fode M, Hatzichristodoulou G, Serefoglu EC, Verze P, Albersen M (2017)
Low-intensity shockwave therapy for erectile dysfunction: is the evidence strong enough?
Nat Rev Urol, 14(10):593-606.

Hatzichristodoulou G, Osmonov D, Kübler H, Hellstrom WJG, Yafi FA (2017)
Contemporary review of grafting techniques for the surgical treatment of Peyronie’s disease.
Sex Med Rev, 5(4):544-552.

Hatzichristodoulou G, Tsambarlis P, Kübler H, Levine LA (2017)
Peyronie’s graft surgery: Tips and tricks from the masters in Andrologic Surgery.
Transl Androl Urol, 6(4):645-656.

Hernández V, Espinos EL, Dunn J, MacLennan S, Lam T, Yuan Y, Compérat E, Cowan NC, Gakis G, Lebrét T, van der Heijden AG, Witjes JA, Ribal MJ (2017)
Oncological and functional outcomes of sexual function-preserving cystectomy compared with standard radical cystectomy in men: A systematic review.
Urol Oncol, Sep;35(9):539.e17-539.e29.

Hofbauer S, Kalogirou C, Roghmann F, Seitz AK, Vallo S, Wezel F, Worst T, Nawroth R (2017)
Modern networks: Topics in the working group "Bladder cancer research" of the GeSRU Academics.
Urologe A, Feb;56(2):202-207.

Kalogirou C, Kocot A, Mulfinger P, Hartmann E, Krebs M, Vergho D, Riedmiller H. (2017) 
Diagnosis and Clinical Management of Ruptured Ileocecal Pouches for Continent Cutaneous Urinary Diversion.
Urol Int, 98(3):274-281.

Kalogirou C, Mulfinger P, Sokolakis I, Krebs M, Kübler H, Riedmiller H, Vergho D (2017) Preoperative C-Reactive Protein Values as a Potential Component in Outcome Prediction Models of Metastasized Renal Cell Carcinoma Patients Receiving Cytoreductive Nephrectomy.
Urologia internationalis, 99(3):297-307.

Kocot A* Kalogirou C*, Vergho D, Riedmiller H (2017)
Long‐term results of ileal ureteric replacement: a 25‐year single‐centre experience.
BJU international, 120(2):273-279.

Kocot A, Riedmiller H (2017)
Fistulas of the urogenital tract after radiotherapy.
Urologe A, Mar;56(3):329-335.

Oelschlaeger M, Sokolakis I, Kalogirou C, Frey L, Riedmiller H, Kübler H, Vergho D (2018)
Repair of an Autologous Saphenous Vein Graft Aneurysm Ten Years after Renal Artery Reconstruction during Live Donor Renal Transplantation.
Urol Int, 101:236–239. [Epub 2017]

Patel V, Collazo Lorduy A, Stern A, Fahmy O, Pinotti R, Galsky MD, Gakis G (2017) Survival after Metastasectomy for Metastatic Urothelial Carcinoma: A Systematic Review and Meta-Analysis.
Bladder Cancer, Apr;27;3(2):121-132.

Riedmiller, H, Kocot, A, & Kalogirou, C (2017)
Serous‐lined, stapled pouch wall plication: initial results of a simple and quick novel continence mechanism in troubleshooting secondary to continent cutaneous urinary diversion.
BJU international, 121(1):155-159.

Rink M, Engel O, Gakis G, Fritsche HM, Vetterlein MW, Soave A, Peine S, Aziz A, Dahlem R, Stenzl A, Burger M, Shariat SF, Fisch M, Gild P (2017)
The effect of AB0 and Rhesus blood grouping systems on oncological outcome in patients undergoing radical nephroureterectomy for upper tract urothelial carcinoma. Urol Oncol, Dec;35(12):671.e17-671.e23.

Schmid SC, Sathe A, Guerth F, Seitz AK, Heck MM, Maurer T, Schwarzenböck SM, Krause BJ, Schulz WA, Stoehr R, Gschwend JE, Retz M; German Bladder Cancer Network, Nawroth R (2017)
Wntless promotes bladder cancer growth and acts synergistically as a molecular target in combination with cisplatin.
Urol Oncol, Sep;35(9):544.e1-544.e10.

Seitz AK, Christensen LL, Christensen E, Faarkrog K, Ostenfeld MS, Hedegaard J, Nordentoft I, Nielsen MM, Palmfeldt J, Thomson M, Jensen MT, Nawroth R, Maurer T, Ørntoft TF, Jensen JB, Damgaard CK, Dyrskjøt L (2017)
Profiling of long non-coding RNAs identifies LINC00958 and LINC01296 as candidate oncogenes in bladder cancer.
Sci Rep, Mar 24;7(1):395.

Seitz AK, Thoene S, Bietenbeck A, Nawroth R, Tauber R, Thalgott M, Schmid S, Secci R, Retz M, Gschwend JE, Ruland J, Winter C, Heck MM (2017)
AR-V7 in Peripheral Whole Blood of Patients with Castration-resistant Prostate Cancer: Association with Treatment-specific Outcome Under Abiraterone and Enzalutamide.
Eur Urol, Nov;72(5):828-834.

Sokolakis I, Dimitriadis F, Psalla D, Karakiulakis G, Kalyvianakis D, Hatzichristou D (2018)
Effects of low-intensity shock wave therapy (LiST) on the erectile tissue of naturally aged rats.
Int J Impot Res, Aug;31(S1):1. [Epub 2017]

Sokolakis, I, Kalogirou, C, Frey, L, Oelschläger, M, Krebs, M, Riedmiller, H, ... & Vergho, D (2017)
Mucin-Poor Mucinous Tubular and Spindle Cell Carcinoma of the Kidney Presented with Multiple Metastases Two Years after Nephrectomy: An Atypical Behaviour of a Rare, Indolent Tumour.
Case reports in urology, Article ID 6597592, 4 p.

Yafi FA, Hatzichristodoulou G, DeLay KJ, Hellstrom WJG (2017)
Review of management options for patients with atypical Peyronie’s disease.
Sex Med Rev, 5(2):211-221.

Bluemel C, Krebs M, Polat B, Linke F, Eiber M, Samnick S, Lapa C, Lassmann M, Riedmiller H, Czernin J, Rubello D, Bley T, Kropf S, Wester HJ, Buck AK, Herrmann K. (2016)
68Ga-PSMA-PET/CT in Patients With Biochemical Prostate Cancer Recurrence and Negative 18F-Choline-PET/CT.
Clin Nucl Med 41(7):515-21.

Bluemel C, Linke F, Herrmann K, Simunovic I, Eiber M, Kestler C, Buck AK, Schirbel A, Bley TA, Wester HJ, Vergho D, Becker A. (2016)
Impact of (68)Ga-PSMA PET/CT on salvage radiotherapy planning in patients with prostate cancer and persisting PSA values or biochemical relapse after prostatectomy.
EJNMMI Res 6(1):78.

Dell'Oglio P, Karnes RJ, Joniau S, Spahn M, Gontero P, Tosco L, Fossati N, Kneitz B, Chlosta P, Graefen M, Marchioro G, Bianchi M, Sanchez-Salas R, Karakiewicz PI, Poppel HV, Montorsi F, Briganti A, European Multicenter Prostate Cancer Clinical and Translational Research Group (EMPaCT). (2016)
Very long-term survival patterns of young patients treated with radical prostatectomy for high-risk prostate cancer.
Urol Oncol 34(5):234.e13-9.

Kalogirou C, Schäfer D, Krebs M, Kurz F, Schneider A, Riedmiller H, Kneitz B, Vergho D. (2016)
Metformin-Derived Growth Inhibition in Renal Cell Carcinoma Depends on miR-21-Mediated PTEN Expression.
Urol Int 96(1):106-15.

Mager R, Daneshmand S, Evans CP, Palou J, Martínez-Salamanca JI, Master VA, McKiernan JM, Libertino JA, Haferkamp A, International Renal Cell Carcinoma-Venous Thrombus Consortium , Haferkamp A, Capitanio U, Carballido JA, Chantada V, Chromecki T, Ciancio G, Daneshmand S, Evans CP, Gontero P, González J, Hohenfellner M, Huang WC, Koppie TM, Libertino JA, Espinós EL, Lorentz A, Martínez-Salamanca JI, Master VA, McKiernan JM, Montorsi F, Novara G, O'Malley P, Pahernik S, Palou J, Moreno JL, Pruthi RS, Faba OR, Russo P, Scherr DS, Shariat SF, Spahn M, Terrone C, Tilki D, Vázquez-Martul D, Donoso CV, Vergho D, Wallen EM, Zigeuner R. (2016)
Renal cell carcinoma with inferior vena cava involvement: Prognostic effect of tumor thrombus consistency on cancer specific survival.
J Surg Oncol 114(6):764-768.

Ardelt PU, Ebbing J, Adams F, Reiss C, Arap W, Pasqualini R, Bachmann A, Wetterauer U, Riedmiller H, Kneitz B. (2015)
An anti-ubiquitin antibody response in transitional cell carcinoma of the urinary bladder.
PLoS ONE 10(3):e0118646.

Briganti A, Karnes RJ, Gandaglia G, Spahn M, Gontero P, Tosco L, Kneitz B, Chun FK, Zaffuto E, Sun M, Graefen M, Marchioro G, Frohneberg D, Giona S, Karakiewicz PI, Van Poppel H, Montorsi F, Joniau S, European Multicenter Prostate Cancer Clinical and Translational Research Group (EMPaCT). (2015)
Natural history of surgically treated high-risk prostate cancer.
Urol Oncol 33(4):163.e7-13.

Gontero P, Sylvester R, Pisano F, Joniau S, Vander Eeckt K, Serretta V, Larré S, Di Stasi S, Van Rhijn B, Witjes AJ, Grotenhuis AJ, Kiemeney LA, Colombo R, Briganti A, Babjuk M, Malmström PU, Oderda M, Irani J, Malats N, Baniel J, Mano R, Cai T, Cha EK, Ardelt P, Varkarakis J, Bartoletti R, Spahn M, Johansson R, Frea B, Soukup V, Xylinas E, Dalbagni G, Karnes RJ, Shariat SF, Palou J. (2015)
Prognostic factors and risk groups in T1G3 non-muscle-invasive bladder cancer patients initially treated with Bacillus Calmette-Guérin: results of a retrospective multicenter study of 2451 patients.
Eur Urol 67(1):74-82.

Herrmann K, Bluemel C, Weineisen M, Schottelius M, Wester HJ, Czernin J, Eberlein U, Beykan S, Lapa C, Riedmiller H, Krebs M, Kropf S, Schirbel A, Buck AK, Lassmann M. (2015)
Biodistribution and radiation dosimetry for a probe targeting prostate-specific membrane antigen for imaging and therapy.
J Nucl Med 56(6):855-61.

Joniau S, Briganti A, Gontero P, Gandaglia G, Tosco L, Fieuws S, Tombal B, Marchioro G, Walz J, Kneitz B, Bader P, Frohneberg D, Tizzani A, Graefen M, van Cangh P, Karnes RJ, Montorsi F, Van Poppel H, Spahn M, European Multicenter Prostate Cancer Clinical and Translational Research Group (EMPaCT) (2015)
Stratification of high-risk prostate cancer into prognostic categories: a European multi-institutional study.
Eur Urol 67(1):157-64.

Joniau S, Spahn M, Briganti A, Gandaglia G, Tombal B, Tosco L, Marchioro G, Hsu CY, Walz J, Kneitz B, Bader P, Frohneberg D, Tizzani A, Graefen M, van Cangh P, Karnes RJ, Montorsi F, van Poppel H, Gontero P, European Multicenter Prostate Cancer Clinical and Translational Research Group (EMPaCT). (2015)
Eur Urol 67(2):319-25.

Kocot A, Riedmiller H. (2015)
Treatment of long-term radiation injuries in the urinary tract.
Urologe A 54(12):1765-71.

Litovkin K, Van Eynde A, Joniau S, Lerut E, Laenen A, Gevaert T, Gevaert O, Spahn M, Kneitz B, Gramme P, Helleputte T, Isebaert S, Haustermans K, Bollen M. (2015)
DNA Methylation-Guided Prediction of Clinical Failure in High-Risk Prostate Cancer.
PLoS ONE 10(6):e0130651.

Moltzahn F, Karnes J, Gontero P, Kneitz B, Tombal B, Bader P, Briganti A, Montorsi F, Van Poppel H, Joniau S, Spahn M. (2015)
Predicting prostate cancer-specific outcome after radical prostatectomy among men with very high-risk cT3b/4 PCa: a multi-institutional outcome study of 266 patients.
Prostate Cancer Prostatic Dis 18(1):31-7.

Nguyen HG, Tilki D, Dall'Era MA, Durbin-Johnson B, Carballido JA, Chandrasekar T, Chromecki T, Ciancio G, Daneshmand S, Gontero P, Gonzalez J, Haferkamp A, Hohenfellner M, Huang WC, Linares Espinós E, Mandel P, Martinez-Salamanca JI, Master VA, McKiernan JM, Montorsi F, Novara G, Pahernik S, Palou J, Pruthi RS, Rodriguez-Faba O, Russo P, Scherr DS, Shariat SF, Spahn M, Terrone C, Vergho D, Wallen EM, Xylinas E, Zigeuner R, Libertino JA, Evans CP. (2015)
Cardiopulmonary Bypass has No Significant Impact on Survival in Patients Undergoing Nephrectomy and Level III-IV Inferior Vena Cava Thrombectomy: Multi-Institutional Analysis.
J Urol 194(2):304-8.

Riedmiller H, Kocot A. (2015)
The devastated bladder outlet: treatment options.
Curr Opin Urol 25(4):352-6.

Tilki D, Hu B, Nguyen HG, Dall'Era MA, Bertini R, Carballido JA, Chandrasekar T, Chromecki T, Ciancio G, Daneshmand S, Gontero P, Gonzalez J, Haferkamp A, Hohenfellner M, Huang WC, Koppie TM, Linares E, Lorentz CA, Mandel P, Martinez-Salamanca JI, Master VA, Matloob R, McKiernan JM, Mlynarczyk CM, Montorsi F, Novara G, Pahernik S, Palou J, Pruthi RS, Ramaswamy K, Rodriguez Faba O, Russo P, Shariat SF, Spahn M, Terrone C, Thieu W, Vergho D, Wallen EM, Xylinas E, Zigeuner R, Libertino JA, Evans CP. (2015)
Impact of synchronous metastasis distribution on cancer specific survival in renal cell carcinoma after radical nephrectomy with tumor thrombectomy.
J Urol 193(2):436-42.

Vergho D, Burger M, Schrammel M, Brookman-May S, Gierth M, Hoschke B, Lopau K, Gilfrich C, Riedmiller H, Wolff I, May M. (2015)
Matched-pair analysis of renal function in the immediate postoperative period: a comparison of living kidney donors versus patients nephrectomized for renal cell cancer.
World J Urol 33(5):725-31.

Gierth M, Fritsche HM, Buchner H, May M, Aziz A, Otto W, Bolenz C, Trojan L, Hermann E, Tiemann A, Müller SC, Ellinger J, Brookman-May S, Stief CG, Tilki D, Nuhn P, Höfner T, Hohenfellner M, Haferkamp A, Roigas J, Zacharias M, Wieland WF, Riedmiller H, Denzinger S, Bastian PJ, Burger M. (2014)
Clinical and pathological nodal staging score for urothelial carcinoma of the bladder: an external validation.
World J Urol 32(2):365-71.

Hailer A, Grunewald TG, Orth M, Reiss C, Kneitz B, Spahn M, Butt E. (2014)
Loss of tumor suppressor mir-203 mediates overexpression of LIM and SH3 Protein 1 (LASP1) in high-risk prostate cancer thereby increasing cell proliferation and migration. Oncotarget 5(12):4144-4153.

Kneitz B, Krebs M, Kalogirou C, Schubert M, Joniau S, van Poppel H, Lerut E, Kneitz S, Scholz CJ, Ströbel P, Gessler M, Riedmiller H, Spahn M. (2014)
Survival in patients with high-risk prostate cancer is predicted by miR-221, which regulates proliferation, apoptosis, and invasion of prostate cancer cells by inhibiting IRF2 and SOCS3.
Cancer Res 74(9):2591-603.

Kocot A, Riedmiller H. (2014)
Management and prevention of complications in open urethral surgery. End-to-end anastomosis and buccal mucosa urethroplasty.
Urologe A 53(7):1006-10.

Litovkin K, Joniau S, Lerut E, Laenen A, Gevaert O, Spahn M, Kneitz B, Isebaert S, Haustermans K, Beullens M, Van Eynde A, Bollen M. (2014)
Methylation of PITX2, HOXD3, RASSF1 and TDRD1 predicts biochemical recurrence in high-risk prostate cancer.
J Cancer Res Clin Oncol 140(11):1849-61.

Loeser A, Katzenberger T, Vergho DC, Kocot A, Burger M, Riedmiller H. (2014)
Frozen section analysis of ureteral margins in patients undergoing radical cystectomy for bladder cancer: differential impact of carcinoma in situ in the bladder on reliability and impact on tumour recurrence in the upper urinary tract.
Urol Int 92(1):50-4.

Martínez-Salamanca JI, Linares E, González J, Bertini R, Carballido JA, Chromecki T, Ciancio G, Daneshmand S, Evans CP, Gontero P, Haferkamp A, Hohenfellner M, Huang WC, Koppie TM, Master VA, Matloob R, McKiernan JM, Mlynarczyk CM, Montorsi F, Nguyen HG, Novara G, Pahernik S, Palou J, Pruthi RS, Ramaswamy K, Faba OR, Russo P, Shariat SF, Spahn M, Terrone C, Tilki D, Vergho D, Wallen EM, Xylinas E, Zigeuner R, Libertino JA. (2014)
Lessons learned from the International Renal Cell Carcinoma-Venous Thrombus Consortium (IRCC-VTC).
Curr Urol Rep 15(5):404.

Schmid M, Steinlein C, Tian Q, Hanlon Newell AE, Gessler M, Olson SB, Rosenwald A, Kneitz B, Fedorov LM. (2014)
Mosaic variegated aneuploidy in mouse BubR1 deficient embryos and pregnancy loss in human.
Chromosome Res 22(3):375-92.

Tilki D, Nguyen HG, Dall'Era MA, Bertini R, Carballido JA, Chromecki T, Ciancio G, Daneshmand S, Gontero P, Gonzalez J, Haferkamp A, Hohenfellner M, Huang WC, Koppie TM, Lorentz CA, Mandel P, Martinez-Salamanca JI, Master VA, Matloob R, McKiernan JM, Mlynarczyk CM, Montorsi F, Novara G, Pahernik S, Palou J, Pruthi RS, Ramaswamy K, Rodriguez Faba O, Russo P, Shariat SF, Spahn M, Terrone C, Vergho D, Wallen EM, Xylinas E, Zigeuner R, Libertino JA, Evans CP. (2014)
Impact of histologic subtype on cancer-specific survival in patients with renal cell carcinoma and tumor thrombus.
Eur Urol 66(3):577-83.

Vergho D, Kneitz S, Rosenwald A, Scherer C, Spahn M, Burger M, Riedmiller H, Kneitz B. (2014)
Combination of expression levels of miR-21 and miR-126 is associated with cancer-specific survival in clear-cell renal cell carcinoma.
BMC Cancer 14:25.

Vergho DC, Kneitz S, Kalogirou C, Burger M, Krebs M, Rosenwald A, Spahn M, Löser A, Kocot A, Riedmiller H, Kneitz B. (2014)
Impact of miR-21, miR-126 and miR-221 as prognostic factors of clear cell renal cell carcinoma with tumor thrombus of the inferior vena cava.
PLoS ONE 9(10):e109877.

Ardelt P, Grünemay N, Strehl A, Jilg C, Miernik A, Kneitz B, Butt E. (2013)
LASP-1, a novel urinary marker for detection of bladder cancer.
Urol Oncol 31(8):1591-8.

Aziz A, Gierth M, Fritsche HM, May M, Otto W, Denzinger S, Wieland WF, Merseburger A, Riedmiller H, Kocot A, Burger M. (2013)
Oncological outcome of primary versus secondary muscle-invasive bladder cancer is comparable after radical cystectomy.
Urol Int 91(1):97-102.

Babjuk M, Burger M, Zigeuner R, Shariat SF, van Rhijn BW, Compérat E, Sylvester RJ, Kaasinen E, Böhle A, Palou Redorta J, Rouprêt M, European Association of Urology. (2013)
EAU guidelines on non-muscle-invasive urothelial carcinoma of the bladder: update 2013.
Eur Urol 64(4):639-53.

Briganti A, Spahn M, Joniau S, Gontero P, Bianchi M, Kneitz B, Chun FK, Sun M, Graefen M, Abdollah F, Marchioro G, Frohenberg D, Giona S, Frea B, Karakiewicz PI, Montorsi F, Van Poppel H, Jeffrey Karnes R, European Multicenter Prostate Cancer Clinical and Translational Research Group (EMPaCT). (2013)
Impact of age and comorbidities on long-term survival of patients with high-risk prostate cancer treated with radical prostatectomy: a multi-institutional competing-risks analysis. Eur Urol 63(4):693-701.

Buchner A, May M, Burger M, Bolenz C, Herrmann E, Fritsche HM, Ellinger J, Höfner T, Nuhn P, Gratzke C, Brookman-May S, Melchior S, Peter J, Moritz R, Tilki D, Gilfrich C, Roigas J, Zacharias M, Hohenfellner M, Haferkamp A, Trojan L, Wieland WF, Müller SC, Stief CG, Bastian PJ. (2013)
Prediction of outcome in patients with urothelial carcinoma of the bladder following radical cystectomy using artificial neural networks.
Eur J Surg Oncol 39(4):372-9.

Burger M, Catto JW, Dalbagni G, Grossman HB, Herr H, Karakiewicz P, Kassouf W, Kiemeney LA, La Vecchia C, Shariat S, Lotan Y. (2013)
Epidemiology and risk factors of urothelial bladder cancer.
Eur Urol 63(2):234-41.

Burger M, Grossman HB, Droller M, Schmidbauer J, Hermann G, Dr?goescu O, Ray E, Fradet Y, Karl A, Burgués JP, Witjes JA, Stenzl A, Jichlinski P, Jocham D. (2013) Photodynamic diagnosis of non-muscle-invasive bladder cancer with hexaminolevulinate cystoscopy: a meta-analysis of detection and recurrence based on raw data.
Eur Urol 64(5):846-54.

Burger M, Oosterlinck W, Konety B, Chang S, Gudjonsson S, Pruthi R, Soloway M, Solsona E, Sved P, Babjuk M, Brausi MA, Cheng C, Comperat E, Dinney C, Otto W, Shah J, Thürof J, Witjes JA, International Consultation on Urologic Disease-European Association of Urology Consultation on Bladder Cancer 2012. (2013)
ICUD-EAU International Consultation on Bladder Cancer 2012: Non-muscle-invasive urothelial carcinoma of the bladder.
Eur Urol 63(1):36-44.

Elias J, Heuschmann PU, Schmitt C, Eckhardt F, Boehm H, Maier S, Kolb-Mäurer A, Riedmiller H, Müllges W, Weisser C, Wunder C, Frosch M, Vogel U. (2013)
Prevalence dependent calibration of a predictive model for nasal carriage of methicillin-resistant Staphylococcus aureus.
BMC Infect Dis 13:111.

Fritsche HM, May M, Denzinger S, Otto W, Siegert S, Giedl C, Giedl J, Eder F, Agaimy A, Novotny V, Wirth M, Stief C, Brookman-May S, Hofstädter F, Gierth M, Aziz A, Kocot A, Riedmiller H, Bastian PJ, Toma M, Wieland WF, Hartmann A, Burger M. (2013)
Prognostic value of perinodal lymphovascular invasion following radical cystectomy for lymph node-positive urothelial carcinoma.
Eur Urol 63(4):739-44.

Gunia S, Burger M, Hakenberg OW, May D, Koch S, Jain A, Birnkammer K, Wieland WF, Otto W, Hofstädter F, Fritsche HM, Denzinger S, Gilfrich C, Brookman-May S, May M. (2013)
Inherent grading characteristics of individual pathologists contribute to clinically and prognostically relevant interobserver discordance concerning Broders' grading of penile squamous cell carcinomas.
Urol Int 90(2):207-13.

Kalogirou C, Spahn M, Krebs M, Joniau S, Lerut E, Burger M, Scholz CJ, Kneitz S, Riedmiller H, Kneitz B. (2013)
MiR-205 is progressively down-regulated in lymph node metastasis but fails as a prognostic biomarker in high-risk prostate cancer.
Int J Mol Sci 14(11):21414-34.

Kocot A, Giessing M. (2013)
Increasing the donor and recipient pool-expanded criteria in living kidney donors. Transplant Proc 45(3):1245-7.

Kunath F, Keck B, Bertz S, Brookman-May S, May M, Vergho D, Hartmann A, Riedmiller H, Wullich B, Burger M. (2013)
Is gender becoming relevant in uro-oncological research? A bibliographical analysis. World J Urol 31(5):1065-72.

Kunath F, Krause SF, Wullich B, Goebell PJ, Engehausen DG, Burger M, Meerpohl JJ, Keck B. (2013)
Bladder cancer--the neglected tumor: a descriptive analysis of publications referenced in MEDLINE and data from the register ClinicalTrials.gov.
BMC Urol 13:56.

Loeser A, Neumann M, Kocot A, Vergho DC, Spahn M, Riedmiller H. (2013)
Serum carcino-embryonic antigen (CEA) and its possible use as tumor marker for secondary tumors in urinary intestinal reservoirs.
Urol Oncol 31(5):644-8.

Loss M, Bald C, Breidenbach T, Engehausen D, Guba M, Klein I, Matevossian E, Müller V, Vergho D, Kleespies A. (2013)
Abdominal organ retrieval: strategies to improve quality.
Chirurg 84(4):263-70.

May M, Burger M, Otto W, Hakenberg OW, Wieland WF, May D, Hofstädter F, Götz S, Niessl N, Fritsche HM, Birnkammer K, Gilfrich C, Peter J, Jain A, Koch S, Lebentrau S, Riedmiller H, Rössler W, Denzinger S, Brookman-May S, Gunia S. (2013)
Ki-67, mini-chromosome maintenance 2 protein (MCM2) and geminin have no independent prognostic relevance for cancer-specific survival in surgically treated squamous cell carcinoma of the penis.
BJU Int 112(4):E383-90.

May M, Ficarra V, Shariat SF, Zigeuner R, Chromecki T, Cindolo L, Burger M, Gunia S, Feciche B, Wenzl V, Aziz A, Chun F, Becker A, Pahernik S, Simeone C, Longo N, Zucchi A, Antonelli A, Mirone V, Stief C, Novara G, Brookman-May S, CORONA and SATURN projects , Young Academic Urologists Renal Cancer Group. (2013)
Impact of clinical and histopathological parameters on disease specific survival in patients with collecting duct renal cell carcinoma: development of a disease specific risk model.
J Urol 190(2):458-63.

Otto W, Denzinger S, Fritsche HM, Burger M, Rößler W, Bertz S, May M, Hartmann A, Hofstädter F, Wieland WF, Eder F. (2013)
Introduction and first clinical application of a simplified immunohistochemical validation system confirms prognostic impact of KI-67 and CK20 for stage T1 urothelial bladder carcinoma: single-center analysis of eight biomarkers in a series of three hundr.
Clin Genitourin Cancer 11(4):537-44.

Rouprêt M, Babjuk M, Compérat E, Zigeuner R, Sylvester R, Burger M, Cowan N, Böhle A, Van Rhijn BW, Kaasinen E, Palou J, Shariat SF, European Association of Urology. (2013)
European guidelines on upper tract urothelial carcinomas: 2013 update.
Eur Urol 63(6):1059-71.

Schubert M, Spahn M, Kneitz S, Scholz CJ, Joniau S, Stroebel P, Riedmiller H, Kneitz B. (2013)
Distinct microRNA expression profile in prostate cancer patients with early clinical failure and the impact of let-7 as prognostic marker in high-risk prostate cancer.
PLoS ONE 8(6):e65064.

Stoehr R, Taubert H, Gaisa NT, Smeets D, Kneitz B, Giedl J, Ruemmele P, Wieland WF, Rau TT, Hartmann A. (2013)
Lack of evidence for frequent MED12 p.L1224F mutation in prostate tumours from Caucasian patients.
J Pathol 230(4):453-6.

Ardelt PU, Woodhouse CR, Riedmiller H, Gerharz EW. (2012)
The efferent segment in continent cutaneous urinary diversion: a comprehensive review of the literature.
BJU Int 109(2):288-97.

Briganti A, Joniau S, Gontero P, Abdollah F, Passoni NM, Tombal B, Marchioro G, Kneitz B, Walz J, Frohneberg D, Bangma CH, Graefen M, Tizzani A, Frea B, Karnes RJ, Montorsi F, Van Poppel H, Spahn M. (2012)
Identifying the best candidate for radical prostatectomy among patients with high-risk prostate cancer.
Eur Urol 61(3):584-92.

Fritsche HM, Aziz A, Eder F, Otto W, Denzinger S, Wieland WF, May M, Hofstädter F, Hartmann A, Burger M. (2012)
Potentially clinically relevant prostate cancer is found more frequently after complete than after partial histopathological processing of radical cystoprostatectomy specimens.
Virchows Arch 461(6):655-61.

Grossman HB, Stenzl A, Fradet Y, Mynderse LA, Kriegmair M, Witjes JA, Soloway MS, Karl A, Burger M. (2012)
Long-term decrease in bladder cancer recurrence with hexaminolevulinate enabled fluorescence cystoscopy.
J Urol 188(1):58-62.

Joniau S, Hsu CY, Gontero P, Spahn M, Van Poppel H. (2012)
Radical prostatectomy in very high-risk localized prostate cancer: long-term outcomes and outcome predictors.
Scand J Urol Nephrol 46(3):164-71.

Kälble T, Hofmann I, Thüroff JW, Stein R, Hautmann R, Riedmiller H, Vergho D, Hertle L, Wülfing C, Truß M, Roth S, von Rundstedt FC, Albers P, Gschwend J, Herkommer K, Humke U, Spahn M, Bader P, Steffens J, Harzmann R, Stief CG, Karl A, Müller SC, Waldner M, Noldus J, Kleinschmidt K, Alken P, Kopper B, Fisch M, Lampel A, Stenzel A, Fichtner J, Flath B, Rübben H, Juenemann KP, Hautmann S, Knipper A, Leusmann D, Strohmaier W, Thon WF, Miller S, Weingärtner K, Schilling A, Piechota H, Becht JE, Schwaibold H, Bub P, Conrad S, Wenderoth U, Merkle W, Rösch W, Otto T, Ulshöfer B, Westenfelder M. (2012)
Secondary malignancies in urinary diversions.
Urologe A 51(4):500, 502-6.

Kocot A, Vergho DC, Riedmiller H. (2012)
Use of bowel segments for ureter reconstruction.
Urologe A 51(7):928-36.

Otto W, May M, Fritsche HM, Dragun D, Aziz A, Gierth M, Trojan L, Herrmann E, Moritz R, Ellinger J, Tilki D, Buchner A, Höfner T, Brookman-May S, Nuhn P, Gilfrich C, Roigas J, Zacharias M, Denzinger S, Hohenfellner M, Haferkamp A, Müller SC, Kocot A, Riedmiller H, Wieland WF, Stief CG, Bastian PJ, Burger M. (2012)
Analysis of sex differences in cancer-specific survival and perioperative mortality following radical cystectomy: results of a large German multicenter study of nearly 2500 patients with urothelial carcinoma of the bladder.
Gend Med 9(6):481-9.

Otto W, Nowrotek A, Burger M, Wieland WF, Rößler W, Denzinger S. (2012)
Sacral neuromodulation as second-line treatment strategy for lower urinary tract symptoms of various aetiologies: experience of a German high-volume clinic].
Aktuelle Urol 43(3):162-6.

Otto W, Rubenwolf PC, Burger M, Fritsche HM, Rößler W, May M, Hartmann A, Hofstädter F, Wieland WF, Denzinger S. (2012)
Loss of aquaporin 3 protein expression constitutes an independent prognostic factor for progression-free survival: an immunohistochemical study on stage pT1 urothelial bladder cancer.
BMC Cancer 12:459.

Papoutsoglou N, Tappe D, Demmer P, Kocot A, Riedmiller H. (2012)
Urinary incontinence due to the presence of necrotic adult Schistosoma haematobium parasite in the bladder following travel to Egypt.
Travel Med Infect Dis 10(4):205-7.

Riedmiller H. (2012)
Comments on nephrectomy - laparoscopic versus robotic.
Urologe A 51(5):669-70.

Spahn M, Briganti A, Capitanio U, Kneitz B, Gontero P, Karnes JR, Schubert M, Montorsi F, Scholz CJ, Bader P, van Poppel H, Joniau S, European Multicenter Prostate Cancer Clinical and Translational Research Group. (2012)
Outcome predictors of radical prostatectomy followed by adjuvant androgen deprivation in patients with clinical high risk prostate cancer and pT3 surgical margin positive disease.
J Urol 188(1):84-90.

Tekgül S, Riedmiller H, Hoebeke P, Ko?vara R, Nijman RJ, Radmayr C, Stein R, Dogan HS, European Association of Urology. (2012)
EAU guidelines on vesicoureteral reflux in children.
Eur Urol 62(3):534-42.

Vergho D, Kocot A, Bauer C, Riedmiller H. (2012)
Insufficiency of the efferent segment in continent cutaneous diversion.
Urologe A 51(4):485-93.